Inventor · disambiguated record
Scott Grindrod
Also filed as: GRINDROD SCOTT
10 granted patents·7 pending applications·38 citations·filing 2009–2025
83Inventor score
Files withSHUTTLE PHARMACEUTICALS INC13BROWN MILTON L1KINSELLA TIMOTHY J1SHUTTLE PHARMACEUTICALS LLC1UNIV GEORGETOWN1
Top patents by PatentIndex Score
17 records- 0190US8816095B2Na channels, disease, and related assays and compositionsBROWN MILTON L·Filed 2009·Granted Aug 26, 2014·34 cites·21 claims
- 0283US12357650B2Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorlylase inhibitors in combination with radiationSHUTTLE PHARMACEUTICALS INC·Filed 2023·Granted Jul 15, 2025·0 cites·14 claims
- 0381US9809539B2Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereofSHUTTLE PHARMACEUTICALS LLC·Filed 2015·Granted Nov 7, 2017·4 cites·6 claims
- 0478US2025302857A1Methods And Compositions For Cancer Therapies That Include Delivery Of Halogenated Thymidines And Thymidine Phosphorylase Inhibitors In Combination With RadiationSHUTTLE PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0577US2023302034A1Methods And Compositions For Cancer Therapies That Include Delivery Of Halogenated Thymidines And Thymidine Phosphorylase Inhibitors In Combination With RadiationSHUTTLE PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0675US12077515B2Selective histone deacetylase inhibitors for the treatment of human diseaseSHUTTLE PHARMACEUTICALS INC·Filed 2022·Granted Sep 3, 2024·0 cites·20 claims
- 0774US2022055988A1Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereofSHUTTLE PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0869US2020317611A1Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereofSHUTTLE PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0969US2024174630A1Selective histone deacetylase inhibitors for the treatment of human diseaseSHUTTLE PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1068US10730834B2Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereofSHUTTLE PHARMACEUTICALS INC·Filed 2017·Granted Aug 4, 2020·0 cites·10 claims
- 1167US11654157B2Methods and compositions for cancer therapies that include delivery of halogenated thymidines and thymidine phosphorylase inhibitors in combination with radiationSHUTTLE PHARMACEUTICALS INC·Filed 2018·Granted May 23, 2023·0 cites·10 claims
- 1265US11407723B2Selective histone deacetylase inhibitors for the treatment of human diseaseSHUTTLE PHARMACEUTICALS INC·Filed 2019·Granted Aug 9, 2022·0 cites·5 claims
- 1364US11584733B2Selective histone deacetylase inhibitors for the treatment of human diseaseSHUTTLE PHARMACEUTICALS INC·Filed 2021·Granted Feb 21, 2023·0 cites·20 claims
- 1463US10745352B2Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereofSHUTTLE PHARMACEUTICALS INC·Filed 2016·Granted Aug 18, 2020·0 cites·4 claims
- 1550US2022065863A1Predictive biomarkers for adverse effects of radiation therapyUNIV GEORGETOWN·Filed 2021·Application pending·0 cites
- 1648US11034667B2Selective histone deacetylase inhibitors for the treatment of human diseaseSHUTTLE PHARMACEUTICALS INC·Filed 2018·Granted Jun 15, 2021·0 cites·6 claims
- 1732US2017266284A1Personalized methods for treating disease by radiosensitizationKINSELLA TIMOTHY J·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Scott Grindrod files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →